Heart valve disease
Conditions
Interventions
Case series:None
Sponsors
West China Hospital of Sichuan University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed as valvular heart disease according to the 2014 American Heart Association/American Heart Association Guidelines for the Management of Patients with Valvular Heart Disease and who have undergone biological valve replacement in our hospital; 2. Patients who were voluntary participation in the study; 3. Patients who are conscious and can communicate normally; 4. The medical data record is complete and clear, and the contact information is correct.
Exclusion criteria
Exclusion criteria: 1. Patients who underwent coronary artery bypass graft or artificial vessel replacement at the same time with biological valve replacement; 2. Patients who has serious hearing or language impairment; 3. Patients with pre-operative neurological and psychiatric diseases and other diseases that seriously affect the quality of life.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Drug compliance; | — |
Secondary
| Measure | Time frame |
|---|---|
| Knowledge of anticoagulant;Self-management;Self-efficacy;Family support;Quality of life; | — |
Countries
China
Contacts
Public ContactMiao Chen
West China Hospital of Sichuan University
Outcome results
None listed